A retrospective analysis of immune checkpoint inhibitors in patients with preexisting organ dysfunction.
Meghana KesireddyAlissa MarrMakayla SchisselApar Kishor GantiPublished in: Cancer (2023)
The current results demonstrate that ICIs are well tolerated by patients who have preexisting organ dysfunction.